Ignite Creation Date:
2024-05-05 @ 5:32 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00479505
Status:
COMPLETED
Last Update Posted:
2011-03-23
First Post:
2007-05-24
Brief Title:
Study The Effects Of Different Doses Of UK-369003 In Men With Overactive Bladder
Sponsor:
Pfizer
Organization:
Pfizer
Study Overview
Official Title:
A Multi-Center Randomised Parallel Group Double-Blind Placebo Controlled Estimation Study To Assess The Efficacy And Safety Of Modified Release UK-369003 In The Treatment Of Men With Storage Lower Urinary Tract Symptoms LUTS With And Without Erectile Dysfunction ED
Status:
COMPLETED
Status Verified Date:
2011-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a 12 week study in which different doses of UK-369003 will be administered to patients with a diagnosis of overactive bladder Patients will complete a series of questionnaires before treatment during treatment and after treatment to assess whether UK-369003 has improved their symptoms of overactive bladder and erectile function
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None